Efficacy, Safety, and Tolerability of NVA237 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Clinical trial NCT01613326 · COMPLETED
Trial details
- NCT number
- NCT01613326
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2013-01-01
- Enrollment
- 657
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.